145
Participants
Start Date
December 7, 2005
Primary Completion Date
October 3, 2007
Study Completion Date
October 3, 2007
SB705498 400 mg
SB705498 400 mg
SB705498 1000 mg
SB705498 1000 mg
Placebo
Placebo
Co-Codamol
Co-Codamol
GSK Investigational Site, Verona
GSK Investigational Site, Seoul
GSK Investigational Site, Croydon
GSK Investigational Site, Leeds
GSK Investigational Site, Manchester
Lead Sponsor
GlaxoSmithKline
INDUSTRY